ZA894742B - Mini-proinsulin,its preparation and use - Google Patents

Mini-proinsulin,its preparation and use

Info

Publication number
ZA894742B
ZA894742B ZA894742A ZA894742A ZA894742B ZA 894742 B ZA894742 B ZA 894742B ZA 894742 A ZA894742 A ZA 894742A ZA 894742 A ZA894742 A ZA 894742A ZA 894742 B ZA894742 B ZA 894742B
Authority
ZA
South Africa
Prior art keywords
proinsulin
mini
insulin
chain
converted
Prior art date
Application number
ZA894742A
Other languages
English (en)
Inventor
Michael Doerschug
Doerschug Michael
Eugen Uhlmann
Uhlmann Eugen
Paul Habermann
Habermann Paul
Gerhard Seipke
Seipke Gerhard
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA894742B publication Critical patent/ZA894742B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA894742A 1988-06-23 1989-06-22 Mini-proinsulin,its preparation and use ZA894742B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3821159 1988-06-23

Publications (1)

Publication Number Publication Date
ZA894742B true ZA894742B (en) 1990-03-28

Family

ID=6357053

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA894742A ZA894742B (en) 1988-06-23 1989-06-22 Mini-proinsulin,its preparation and use

Country Status (18)

Country Link
EP (1) EP0347781B1 (da)
JP (1) JP3043764B2 (da)
KR (1) KR0139629B1 (da)
AT (1) ATE101620T1 (da)
AU (1) AU611303B2 (da)
CA (1) CA1341211C (da)
DE (1) DE58906966D1 (da)
DK (1) DK175182B1 (da)
ES (1) ES2061797T3 (da)
FI (1) FI102076B (da)
HK (1) HK1006023A1 (da)
HU (3) HU214704B (da)
IE (1) IE62511B1 (da)
IL (1) IL90694A (da)
NO (1) NO302376B1 (da)
NZ (1) NZ229645A (da)
PT (1) PT90939B (da)
ZA (1) ZA894742B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294656B1 (en) 1995-07-25 2001-09-25 Novartis Corporation Transforming growth factor β crystals

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
US5358857A (en) * 1989-08-29 1994-10-25 The General Hospital Corp. Method of preparing fusion proteins
US5227293A (en) * 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
NZ239652A (en) * 1990-09-05 1992-09-25 Hoechst Ag Hydrolysis of preproinsulin to insulin and analogues using clostripain and optionally carboxypeptidase
CZ342492A3 (en) * 1991-11-26 1993-06-16 Lilly Co Eli Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised
DK0600372T3 (da) 1992-12-02 1997-08-11 Hoechst Ag Fremgangsmåde til fremstilling af proinsulin med korrekt forbundne cystinbroer.
DE59409816D1 (de) * 1993-04-27 2001-09-13 Hoechst Ag Amorphe monosphärische Formen von Insulinderivaten
WO1995016708A1 (en) * 1993-12-17 1995-06-22 Novo Nordisk A/S Proinsulin-like compounds
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
DE19544233A1 (de) 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
DE59711533D1 (de) 1996-07-26 2004-05-27 Aventis Pharma Gmbh Insulinderivate mit erhöhter Zinkbindung
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19915938A1 (de) * 1999-04-09 2000-10-19 Aventis Pharma Gmbh Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung
DE10108100A1 (de) * 2001-02-20 2002-08-29 Aventis Pharma Gmbh Verwendung supersekretierbarer Peptide in Verfahren zu deren Herstellung und paralleler Verbesserung der Exportate eines oder mehrerer anderer Polypeptide von Interesse
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
ES2500918T3 (es) 2001-12-21 2014-10-01 Human Genome Sciences, Inc. Proteínas de fusión de albúmina e interferón beta
DE602004014251D1 (de) * 2003-01-31 2008-07-17 Organon Nv Verfahren zur proteinisolierung unteranoxischen bedingungen
BRPI0823004B8 (pt) 2008-08-07 2021-05-25 Biocon Ltd processo para preparação de compostos de insulina
RU2447149C1 (ru) * 2011-03-24 2012-04-10 Винсорт Менеджемент Инк РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pMSIN4, КОДИРУЮЩАЯ ГИБРИДНЫЙ ПОЛИПЕПТИД - ПРЕДШЕСТВЕННИК ИНСУЛИНА ЧЕЛОВЕКА, ШТАММ BL21(DE3)/pMSIN4-ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ИНСУЛИНА ЧЕЛОВЕКА, СПОСОБ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ИНСУЛИНА ЧЕЛОВЕКА
DK2739646T3 (da) 2011-05-10 2018-02-26 Stefan Hermann Omfattende buffersystem til renaturering af human proinsulin eller proinsulin-derivater
CN102849910A (zh) * 2012-10-10 2013-01-02 清华大学深圳研究生院 一种从污泥中回收腐殖酸并改善污泥厌氧消化的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294656B1 (en) 1995-07-25 2001-09-25 Novartis Corporation Transforming growth factor β crystals

Also Published As

Publication number Publication date
JPH0285298A (ja) 1990-03-26
HU214704B (hu) 2000-03-28
ES2061797T3 (es) 1994-12-16
PT90939A (pt) 1989-12-29
IL90694A0 (en) 1990-01-18
IE62511B1 (en) 1995-02-08
IL90694A (en) 1995-07-31
DE58906966D1 (de) 1994-03-24
FI893046A (fi) 1989-12-24
EP0347781B1 (de) 1994-02-16
NO892597L (no) 1989-12-27
HK1006023A1 (en) 1999-02-05
NO302376B1 (no) 1998-02-23
FI102076B1 (fi) 1998-10-15
HUT52548A (en) 1990-07-28
HU211552A9 (en) 1995-12-28
AU3671889A (en) 1990-01-04
EP0347781A2 (de) 1989-12-27
FI102076B (fi) 1998-10-15
CA1341211C (en) 2001-03-27
DK175182B1 (da) 2004-06-28
AU611303B2 (en) 1991-06-06
DK309989D0 (da) 1989-06-22
EP0347781A3 (en) 1990-05-09
NO892597D0 (no) 1989-06-22
IE892032L (en) 1989-12-23
JP3043764B2 (ja) 2000-05-22
KR0139629B1 (ko) 1998-07-01
FI893046A0 (fi) 1989-06-21
ATE101620T1 (de) 1994-03-15
KR910000796A (ko) 1991-01-30
PT90939B (pt) 1994-11-30
DK309989A (da) 1989-12-24
NZ229645A (en) 1991-02-26

Similar Documents

Publication Publication Date Title
IE892032L (en) Mini-proinsulin, its preparation and use
AU2357488A (en) Pulse oximeter sensor
LTIP712A (en) Process for the preparation of insulin
HU914009D0 (en) Process for the production of short peptides with insulin effect
ATE88354T1 (de) Koerperqualitaet.
IL89634A0 (en) Preparation of a pyrrole derivative
DE69018903D1 (de) Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme.
MX9705667A (es) Derivados de insulina con union a zinc incrementada.